References
- Nieto-FontarigoJJGonzalez-BarcalaFJSan JoseEAriasPNogueiraMSalgadoFJCD26 and asthma: a comprehensive reviewClinic Rev Allerg Immunol Epub2016825
- WagnerLKlemannCStephanMvon HorstenSUnravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and/or structural homologue (DASH) proteinsClin Exp Immunol2016184326528326671446
- ZhongJGongQGoundASrinivasamaharajSRajagopalanSRecent advances in dipeptidyl-peptidase-4 inhibition therapy: Lessons from the bench and clinical trialsJ Diabetes Res2015201560603126075284
- MamgainSMathurSKothiyalPImmunomodulatory activity of DPP4J Pharmacol Clin Toxicol201311006
- OmarBAhrénBPleiotropic mechanisms for the glucose-lowering action of DPP-4 inhibitorsDiabetes20146372196220224962916
- StruyfSProostPScholsDCD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin, by affecting its interaction with CC chemokine receptor 3J Immunol199916284903490910202035
- ForsmannUStoetzerCStephanMInhibition of CD26/dipeptidyl peptidase IV enhances CCL11/eotaxin-mediated recruitment of eosinophils in vivoJ Immunol200818121120112718606664
- ProostPDe MeesterIScholsDAmino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infectionJ Biol Chem199827313722272279516414
- YanSGebnerRDietelSchmiedekUFanHEnhanced ovalbumin-induced airway inflammation in CD26-/- miceEur J Immunol201242253354022101691
- NaderMAInhibition of airway inflammation and remodelling by sitagliptin in murine chronic asthmaInter Immunopharmacol2015292761769
- ShioburaTChibanaKWatanabeTDipeptidyl peptidase-4 is highly expressed in bronchial epithelial cells of untreated asthma and it increases cell proliferation along with fibronectin production in airway constitutive cellsRespir Res2016172826975422
- van der VeldenVHWierenga-WolfAFAdriaansen-SoetingWCOverbeekSEMöllerGMHoogstedenHCVersnelMAExpression of aminopeptidase N and dipeptidyl peptidase IV in the healthy and asthmatic bronchusClin Exp Allergy1998281110120
- LunSWWongCKKoFWHuiDSLamCWIncreased expression of plasma and CD4+ T lymphocyte costimulatory molecule CD26 in adult patients with allergic asthmaJ Clin Immunol200727443043717525828
- Giovannini-ChamiLMarcetBMoreilhonCDistinct epithelial gene expression phenotypes in childhood respiratory allergyEur Respir J20123951197120522005912
- RocheNPostmaDSColiceGDifferential effects of inhaled corticosteroids in smokers/ex-smokers and nonsmokers with asthmaAm J Respir Crit Care Med2015191896096425876207
- IsraelERocheNMartinRJIncreased dose of inhaled corticosteroid versus add-on long-acting β-agonist for step-up therapy in asthmaAnn Am Thorac Soc201512679880625756308
- ColiceGMartinRJIsraelEAsthma outcomes and costs of therapy with extrafine beclomethasone and fluticasoneJ Allergy Clin Immunol20131321455423591272
- PriceDThomasMHaughneyJReal-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthmaRespir Med20131077987100023643486
- JacobCHaasJSBechtelBKardosPBraunSAssessing asthma severity based on claims data: a systematic reviewEur J Health Econ201718222724126931557
- HolmanRMetformin as first choice in oral diabetes treatment: the UKPDS experienceJourn Annu Diabetol Hotel Dieu2007132018613325
- ChangHYWeinerJPRichardsTMBleichSNSegalJBValidating the adapted Diabetes Complications Severity Index in claims dataAm J Manag Care2012181172172623198714
- DeyoRACherkinDCCiolMAAdapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJ Clin Epidemiol19924566136191607900
- AdamsRJWilsonDHTaylorAWCoexistent chronic conditions and asthma quality of life: a population-based studyChest2006129228529116478843
- TraversJMarshSWilliamsMExternal validity of randomised controlled trials in asthma: to whom do the results of the trials apply?Thorax200762321922317105779
- PriceDWilsonAMChisholmARigazioABurdenAThomasMKingCPredicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practiceJ Asthma Allergy2016911226793004
- VelentgasPDreyerNANourjahPSmithSRTorchiaMMDeveloping a Protocol for Observational Comparative Effectiveness Research: A User’s GuideRockville, MDAgency for Healthcare Research and Quality2013
- BrightlingCEChanezPLeighREfficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trialLancet Respir Med20153969270126231288